UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017843
Receipt number R000020674
Scientific Title Development of photodynamic diagnosis and photodynamic therapy using 5-aminolevulinic acid for bone and soft tissue tumors.
Date of disclosure of the study information 2015/07/01
Last modified on 2015/06/09 15:58:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of photodynamic diagnosis and photodynamic therapy using 5-aminolevulinic acid for bone and soft tissue tumors.

Acronym

Development of photodynamic therapy for bone and soft tissue tumors.

Scientific Title

Development of photodynamic diagnosis and photodynamic therapy using 5-aminolevulinic acid for bone and soft tissue tumors.

Scientific Title:Acronym

Development of photodynamic therapy for bone and soft tissue tumors.

Region

Japan


Condition

Condition

one and soft tissue tumors

Classification by specialty

Orthopedics

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Development of photodynamic diagnosis and photodynamic therapy using 5-aminolevulinic acid for bone and soft tissue tumors.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Recurrence rate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Device,equipment

Interventions/Control_1

Internal use of 5-aminolevulinic acid

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Diagnosis of bone and soft tissue tumor

Key exclusion criteria

No-consent

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasuo Yazawa

Organization

Saitama Medical University International Medical Center

Division name

Bone and soft tissue oncology

Zip code


Address

Saitamaken hidakashi yamane 1397-1

TEL

042-984-4111

Email

yyazawa@saitama-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Taketo Okubo

Organization

Saitama Medical University International Medical Center

Division name

Bone and soft tissue oncology

Zip code


Address

Saitamaken hidakashi yamane 1397-1

TEL

042-984-4111

Homepage URL


Email

tohkubo@juntendo.ac.jp


Sponsor or person

Institute

Bone and soft tissue oncology, Saitama Medical University International Medical Center

Institute

Department

Personal name



Funding Source

Organization

Saitama Medical University International Medical Center

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2015 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2015 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 06 Month 09 Day

Last modified on

2015 Year 06 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020674


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name